medigraphic.com
ISSN 0035-0052 (Print)

2001, Number 2

<< Back Next >>

Rev Mex Pediatr 2001; 68 (2)

Hospital infections in a pediatric service of a third-level hospital

Martínez-Rojano H, Anaya GSV, Gorbea RMC

Language: Spanish
References: 38
Page: 56-65
PDF size: 106.59 Kb.


ABSTRACT

Objective: To know the epidemiology of nosocomial infections in a pediatric service in a third level hospital in Mexican Institute of Social Security.
Patients and methods: We revised the clinical and microbiological report of all cases of nosocomial infections between January 1993 to December 1997. The nosocomial infection was defined according CDC criterion Atlanta.
Results: The relation of nosocomial or intra-hospitalary infections was between 6.6 to 15.8 events by 100 passing out the lethality was 6.9%. The more frequent nosocomial infections were pneumonia, gastroenteritis, phlebitis, varicella and infections urinary. The microbiological agents in frequency order were: Staphylococcus coagulasa-negatives, E. coli, P. aeruginosa, K. pneumoniae and C. albicans, all microorganisms presented resistance to more frequent antibiotics of common use.
Conclusions: To know the more frequents factors to predispose to nosocomial infections and microbiological resistance behaviors, will be easy the control of nosocomial infections and prevent it, to adopt strong measures in security and will be less events in this patients.


REFERENCES

  1. Ponce de León S, Frausto RS, López EJ, Oliveros RC, Jiménez HM. Infecciones nosocomiales: tendencias seculares de un programa de control en México. Salud Pública Méx 1999; 41 1: S5-S11.

  2. Angulo GD. Infecciones en el niño con cáncer En: Navarrete NS, Muñoz HO, Santos PJI, Infecciones intrahospitalarias en pediatría, McGraw Hill Interamericana, México, D.F.,1998: 119-124.

  3. Plsek PE. Collaborating across organizational boundaries to improve the quality of care. Am J Infect Control 1997; 25: 85-95.

  4. Ávila FC, Cruz Casta M, Patrón AE, León RA. Prevalencia de infecciones nosocomiales en niños: encuesta de 21 hospitales en México. Salud Pública Méx. 1999; 41 (suppl)1: S18-S25.

  5. Barry AL, Thorsberry C. Susceptibility test: Diffusion Tests Procedures In: Lennette EH, Balows A, Haussler WJ, Shadomy HJ. Manual of Clinical Microbiology, 4th Ed., American Society for Microbiology, Washington DC, 1985: 978-987.

  6. Mar JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: A statement by the Infectious Diseases National Committee for Clinical Laboratory Standards (NCCLS) Performance Standards for Antimicrobial Susceptibility Testing; Sixth Informational Supplement. Wayne, Pennsylvania, 1995.

  7. Gaytán-Meza JJ, Mancilla-Ramírez J, Arredondo-García JL, Alcará-Padilla L, Ramírez-Valdivia JM y cols. Etiología de sepsis neonatal y sensibilidad a los antibióticos en el nuevo Hospital Civil de Guadalajara. Enferm Infecc Microbiol 1996; 16: 90-85.

  8. Macías-Hernández AE, Hernández-Ramos I, Muñoz-Barret JM, Juan M, Vargas SE et al. Pediatric primary gramnegative nosocomial bacteremia: A possible relationship with infusate contamination. Infect Control Hosp Epidemiol 1996; 17: 276-80.

  9. Mejía VC. Infecciones relacionadas al uso de catéteres vasculares: En: Navarrete NS, Muñoz HO, Santos PJI, ed. Infecciones intrahospitalarias en pediatría. México, D.F.: McGram-Hill Interamericana 1998: 125-131.

  10. Sherertz RJ. Surveillance for infections associated with vascular catheters. Infect Control Hosp Epidemiol 1996; 17: 746-752.

  11. Red Hospitalaria de Vigilancia Epidemiológica (RHOVE) Coordinación de vigilancia Epidemiológica. Subsecretaría de Prevención y Control de Enfermedades. Secretaría de Salud México 1997.

  12. Ávila FC. Evaluación del impacto económico y la mortalidad de las infecciones nosocomiales en pediatría. Enferm Infec Microbiol 1996; 16: 53.

  13. Navarrete NS, Sánchez AG. Costos secundarios por infecciones nosocomiales en dos unidades pediátricas de cuidados intensivos. Salud Public Mex 1999; 41 suppl 1: S51-S58.

  14. Goldman DA, Weinstein RA, Wenzel RP. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: A challenge to hospital leadership. JAMA 1996; 275: 234-40.

  15. Ponce de León RS, Barrido ME, Rangel FMS, Soto HJL, Wey BS y cols. Organización y responsabilidades para la prevención y control de infecciones intrahospitalarias. En: Ponce de León RS, Barridó ME, Rangel FMS, Soto HJL, ed. Manual de prevención y control de infecciones hospitalarias. México, D.F.: Organización Mundial de la Salud/Organización Panamericana de la Salud 1996; 10-17.

  16. Gaynes R. Antibiotic resistance in ICUs: A multifaceted problem, requiring a multifaceted solution. Infect Control Hosp Epidemiol 1995; 16: 328-330.

  17. Koiwai EK, Nahas HC. Subacute bacterial endocarditis following cardiac surgery. Arch Surg 1956; 73: 272-278.

  18. Denton C, Pappas EG, Uricchio JF, Goldberg H, Likoff W. Bacterial endocarditis following cardiac surgery. Circulation 1955; 15: 525-531.

  19. Ronan A, Hogg FG, Klug FG. Cerebrospinal fluid infections in children. Pediatric Infect Dis J 1995; 14: 782-786.

  20. Kurlat I, Corral G, Oliveira F, Farinella G, Alvarez E. Infection control strategies in a neonatal intensive care unit in Argentina. Journal of Hospital Infection 1998; 40: 149-154.

  21. Pollock EMM, Ford-Jones EL, Rebeyka L, Mindorff CM, Bohn DJ et al. Early nosocomial infections in pediatric cardiovascular surgery patients. Crit Care Med 1990; 18: 378-384.

  22. Solórzano SF, Miranda MG, Leaños MB, Díaz PH. Factores de riesgo para sepsis en pacientes pediátricos por Staphylococcus coagulasa negativa. Bol Med Hosp Infant Mex 1994; 51: 384-388.

  23. Beck-Saque CM, Jarvis WR . National nosocomial infections surveillance system secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J lnfect Dis 1993; 167: 1247-1251.

  24. Kloos WE, Bannarman TL. Update on clinical significance of coagulasa-negative staphylococci. Clin Microbiol Rev 1994; 7: 117-140.

  25. Vaqué J, Rosselló J, Trilla A, Monge V, García-Caballero J et al. Nosocomial infections in Spain: Results of five nationwide serial prevalence surveys (EPINEE project, 1990 to 1994). Infect Control Hosp Epidemiol 1996; 17: 293-297.

  26. Wiblin RT, Wenzel RP. The Infection Control Committee. Infect Control Hosp Epidemiol 1996; 17: 44-46.

  27. Cornwell EE, Belzberg H, Berne VT, Dougherty RW, Morales RI et al. The pattern of fungal infections in critically ill surgical patients. Am Surgeon 1995; 61: 847-850.

  28. Escobar PB. Factores de riesgo para el desarrollo de ependimitis ventricular posderivación del LCR en niños (tesis). México, D.F.: UNAM, 1997.

  29. Ronan A, Hogg FG, Klug FG. Cerebrospinal fluid infections in children. Pediatric Infect Dis J 1995; 14: 782-786.

  30. Zaidi M, Martin G, Rosado R. Epidemia de neumonía asociada a ventilación mecánica en Mérida, Yucatán. Salud Pública Mex 1999; 41 suppl I: S38-S43.

  31. Gaynes R. Antibiotic resistance in ICUs: A multifaceted problem requiring a multifaceted solution. Infect Control Hosp Epidemiol 1995; 16: 328-330.

  32. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis in Candida species. Clin Infect Dis 1995; 20: 1526-1530.

  33. May J, Brooks S, Johnstone D, Macfie J. Does the addition of pre-operative skin preparation with povidone-iodine reduce growth sepsis following arterial surgery? J Hosp Infect 1993; 24: 153-156.

  34. Wenzel RP. Nosocomial candidemia risk factors and attributable mortality. Clin Infect Dis 1995; 20: 1531-1534.

  35. Karanfil LV, Murphy M, Josephson A. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992; 13: 195-200.

  36. Solórzano SF, Leaños MB, Miranda NG, Díaz PH. Additional information of antimicrobial susceptibility of enterococci in Mexico. Rev Invest Clin 1996; 48: 407-408.

  37. Chenoweth EC, Schaberg RD. Enterococcus species In: Wenzel RP, Prevention and control of nosocomial infections, 3a Edition. Baltimore: Williams and Wilkins 1997; 334-345.

  38. Moellering RC Jr. Emergence of enterococcus as a significant pathogen. Clin Infect Dis 1992; 14: 1173-1178.




2020     |     www.medigraphic.com